医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Saudi Arabia Hosts The Brain Forum

2013年11月08日 PM04:25
このエントリーをはてなブックマークに追加


 

JEDDAH, Saudi Arabia

Jeddah, Saudi Arabia will be hosting the first of its kind symposium in the Middle East region that will bring together some of the world’s top inspirational thinkers and pioneers in the field of Brain Research and Personalized Healthcare.

Renowned scientists from all over the world will present their latest discoveries and hold open discussions on the future of brain research and related healthcare challenges. The Forum will also present new tools, technologies and other personalized healthcare innovations that could improve the diagnosis, management and treatment of brain disorders.

The Forum will provide physicians, scientists, and business executives from both the public and private sectors opportunities to exchange ideas and share their thoughts on the future healthcare challenges and opportunities.

Dr. Walid Juffali, who is hosting the event, said the Forum comes within the framework of initiatives undertaken by the Saudi government to address national health priorities, including neurodegenerative diseases and brain disorders. He believes the Kingdom will benefit, greatly, from the leading scientists and global experts, and this will contribute to the improvement of medical technology as well as to support the government’s efforts. He added that the Forum also falls under the tenets and guidelines of the W Science initiative funded by Dr. Walid Juffali.

W Science initiative was launched by Dr. Walid Juffali to support outstanding scientific projects and facilitate collaborations among leading scientists working at the interfaces of different scientific disciplines to address unmet medical needs and improve the quality of personalized healthcare.

The speakers include leading experts on the subject, from some of the world’s top institutions, who are playing major roles in shaping the future of brain research through their pioneering work and leadership of major international scientific initiatives.

The Forum was set up in conjunction with a Scientific Committee which included Professor Dr. Hilal A. Lashuel, Associate Professor of Neuroscience, Director of the Laboratory of Chemical Biology of Neurodegeneration, Brain Mind Institute, Swiss Federal Institute of Technology Lausanne, Switzerland; Professor Christopher Toumazou from Imperial College; Dr. Jamil El-Imad, Managing Director and Chief Scientist of NeuroPro, a Swiss-based medical technology research, design and commercialization company focused on bringing to the healthcare community innovative, safe and low-cost solutions to applied neural signal analysis; Professor Saeed Bohlega, professor and senior neurology consultant at the Department of Neurology at King Faisal Specialist Hospital in Riyadh, and the President of Saudi Neurology Society; and Dr. Mohammed Jan, Professor & Consultant of Pediatric Neurology & Clinical Neurophysiology, Department of Pediatrics, Faculty of Medicine, (KAU).

For registration, visit our website: www.thebrainforum.org where you can also watch the live streaming of the event.

*Source: ME NewsWire

View the full release online by clicking here: http://www.me-newswire.net/news/9113/en

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131107006863/en/

CONTACT

Headline Communication
Alshaimaa Adel Almaddah,
+966-56-300-3080
aalmaddah@headlineme.com
www.headlineme.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表